Inflammatory Bowel Disease in Dogs: A Complete Guide
Inflammatory bowel disease (IBD) is a chronic gastrointestinal condition in which the intestinal lining becomes persistently infiltrated with inflammatory cells, disrupting normal digestion and nutrient absorption. It is one of the most common causes of chronic vomiting and diarrhoea in dogs and can significantly impair quality of life if not managed appropriately. Understanding IBD — including its types, how it is diagnosed, and the treatment options available — is important for owners of affected dogs.
What Is Canine IBD?
IBD is not a single disease but a group of disorders classified according to the type of inflammatory cells found in intestinal biopsies. The most common types are:
- Lymphoplasmacytic enteritis (LPE) — the most common form; the intestinal wall is infiltrated with lymphocytes and plasma cells
- Eosinophilic gastroenteritis — characterised by eosinophil infiltration; often associated with food hypersensitivity or parasitic infection
- Granulomatous enteritis — rare and typically more severe, often associated with specific bacterial infections (including Mycobacterium)
- Lymphangiectasia — dilation of the intestinal lymphatic vessels, causing protein loss into the gut lumen; associated with severe hypoalbuminaemia
An important distinction must be drawn between IBD and intestinal lymphoma, a form of cancer that can produce an almost identical clinical and histological picture. Distinguishing between severe IBD and low-grade intestinal lymphoma requires advanced pathological techniques and is one of the most challenging problems in veterinary gastroenterology.
Causes and Risk Factors
The underlying cause of canine IBD is not fully understood. Current evidence suggests it results from an abnormal immune response to intestinal bacteria or dietary antigens in genetically predisposed dogs. Contributing factors may include:
- Disruption of the normal intestinal microbiome (dysbiosis)
- Defects in intestinal barrier function
- Genetic predisposition — certain breeds including the German Shepherd, Irish Setter, Soft-Coated Wheaten Terrier (particularly prone to protein-losing enteropathy), and Basenji are overrepresented
- Dietary hypersensitivity or allergy
Clinical Signs
The clinical presentation of IBD depends on which part of the gastrointestinal tract is most affected. Signs may be subtle and intermittent initially, progressing to more severe and persistent over time:
- Chronic or intermittent vomiting — may contain bile or undigested food
- Chronic diarrhoea — can be large bowel (frequent, small volume, mucous) or small bowel (large volume, watery) in character
- Weight loss — often progressive, despite a good or even increased appetite
- Reduced appetite or intermittent inappetence
- Protein-losing enteropathy — in severe cases, proteins leak from the damaged intestinal wall, causing oedema (swelling of the limbs), ascites (fluid in the abdomen), and pleural effusion
- Borborygmi and flatulence
Diagnosis
Diagnosing IBD requires ruling out other common causes of chronic gastrointestinal signs:
- Parasites — faecal examination and PCR testing for Giardia, Cryptosporidium, and worms; treatment with a broad-spectrum anthelmintic is often undertaken regardless
- Food-responsive disease — an 8 to 12-week dietary elimination trial to rule out food-responsive enteropathy (a subset of dogs respond to diet change alone and may not require immunosuppression)
- Antibiotic-responsive diarrhoea — some dogs respond to antibiotics targeting intestinal dysbiosis
- Exocrine pancreatic insufficiency (EPI) — diagnosed with a serum trypsin-like immunoreactivity (TLI) test
- Cobalamin (vitamin B12) deficiency — measured by serum cobalamin; deficiency is common in IBD and must be corrected as it impairs intestinal repair
Definitive diagnosis of IBD requires endoscopy and intestinal biopsy. Endoscopy allows direct visualisation of the mucosal surface and collection of biopsy samples for histopathological analysis. Biopsies are graded using WSAVA standardised criteria. In some cases, full-thickness biopsies obtained via laparoscopy or laparotomy are needed when endoscopic biopsies are insufficient.
Blood tests typically reveal hypoalbuminaemia and hypocobalaminaemia in significant IBD. Imaging (abdominal ultrasound) can reveal intestinal wall thickening, altered layering, and enlarged lymph nodes.
Treatment
Dietary Management
Diet is central to IBD management. Highly digestible, novel protein or hydrolysed protein diets reduce the antigenic load on the intestinal immune system. Some dogs with food-responsive disease respond to diet alone, without requiring immunosuppressive medication. Premium gastrointestinal diets from Royal Canin, Hills, and Purina — all available at Zooplus — provide good digestibility and controlled antigen profiles.
Cobalamin Supplementation
Cobalamin deficiency must be corrected before other treatments can be optimally effective. Weekly subcutaneous injections for 6 weeks, followed by monthly dosing, is a standard protocol. Oral cobalamin supplementation at high doses is increasingly recognised as effective and more convenient for owners.
Immunosuppressive Therapy
For dogs that do not respond to diet and antibiotic trials, immunosuppressive therapy is indicated:
- Prednisolone — the first-line immunosuppressive agent; effective but carries side effects with prolonged use
- Azathioprine or chlorambucil — added when prednisolone alone is insufficient, or to allow prednisolone dose reduction
- Budesonide — a locally acting steroid with reduced systemic effects; useful for small intestinal IBD
Prognosis
Prognosis depends on the severity of disease, the underlying type of IBD, and the degree of hypoalbuminaemia. Many dogs with mild to moderate IBD can achieve good to excellent control with appropriate management. Dogs with severe protein-losing enteropathy have a more guarded prognosis. Long-term follow-up with repeat blood tests, body weight monitoring, and periodic reassessment of medication requirements is essential.